Knorr B - Search Results

1

Pharmacokinetics and safety of montelukast oral granules in children 1 to 3 months of age with bronchiolitis.

Kearns GL, Lu S, Maganti L, Li XS, Migoya E, Ahmed T, Knorr B, Reiss TF. Kearns GL, et al. Among authors: knorr b. J Clin Pharmacol. 2008 Apr;48(4):502-11. doi: 10.1177/0091270008314251. Epub 2008 Feb 22. J Clin Pharmacol. 2008. PMID: 18296556 Clinical Trial.

2

Pharmacokinetics and safety of montelukast in children aged 3 to 6 months.

Knorr B, Maganti L, Ramakrishnan R, Tozzi CA, Migoya E, Kearns G. Knorr B, et al. J Clin Pharmacol. 2006 Jun;46(6):620-7. doi: 10.1177/0091270006288324. J Clin Pharmacol. 2006. PMID: 16707408 Clinical Trial.

3

Pharmacokinetics of montelukast in asthmatic patients 6 to 24 months old.

Migoya E, Kearns GL, Hartford A, Zhao J, van Adelsberg J, Tozzi CA, Knorr B, Deutsch P. Migoya E, et al. Among authors: knorr b. J Clin Pharmacol. 2004 May;44(5):487-94. doi: 10.1177/0091270004264970. J Clin Pharmacol. 2004. PMID: 15102869 Clinical Trial.

4

Montelukast dose selection in children ages 2 to 5 years: comparison of population pharmacokinetics between children and adults.

Knorr B, Nguyen HH, Kearns GL, Villaran C, Boza ML, Reiss TF, Rogers JD, Zhang J, Larson P, Spielberg S. Knorr B, et al. J Clin Pharmacol. 2001 Jun;41(6):612-9. doi: 10.1177/00912700122010492. J Clin Pharmacol. 2001. PMID: 11402629 Clinical Trial.

5

Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children.

Bisgaard H, Flores-Nunez A, Goh A, Azimi P, Halkas A, Malice MP, Marchal JL, Dass SB, Reiss TF, Knorr BA. Bisgaard H, et al. Am J Respir Crit Care Med. 2008 Oct 15;178(8):854-60. doi: 10.1164/rccm.200706-910OC. Epub 2008 Jun 26. Am J Respir Crit Care Med. 2008. PMID: 18583576 Clinical Trial.

6

A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma.

Camargo CA Jr, Gurner DM, Smithline HA, Chapela R, Fabbri LM, Green SA, Malice MP, Legrand C, Dass SB, Knorr BA, Reiss TF. Camargo CA Jr, et al. J Allergy Clin Immunol. 2010 Feb;125(2):374-80. doi: 10.1016/j.jaci.2009.11.015. J Allergy Clin Immunol. 2010. PMID: 20159247 Clinical Trial.

7

Intermittent or daily montelukast versus placebo for episodic asthma in children.

Valovirta E, Boza ML, Robertson CF, Verbruggen N, Smugar SS, Nelsen LM, Knorr BA, Reiss TF, Philip G, Gurner DM. Valovirta E, et al. Ann Allergy Asthma Immunol. 2011 Jun;106(6):518-26. doi: 10.1016/j.anai.2011.01.017. Epub 2011 Mar 4. Ann Allergy Asthma Immunol. 2011. PMID: 21624752 Clinical Trial.

8

Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma.

van Adelsberg J, Moy J, Wei LX, Tozzi CA, Knorr B, Reiss TF. van Adelsberg J, et al. Among authors: knorr b. Curr Med Res Opin. 2005 Jun;21(6):971-9. doi: 10.1185/030079905X48456. Curr Med Res Opin. 2005. PMID: 15969897 Clinical Trial.

9

Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions.

Bisgaard H, Skoner D, Boza ML, Tozzi CA, Newcomb K, Reiss TF, Knorr B, Noonan G. Bisgaard H, et al. Among authors: knorr b. Pediatr Pulmonol. 2009 Jun;44(6):568-79. doi: 10.1002/ppul.21018. Pediatr Pulmonol. 2009. PMID: 19449366 Review.

10

Reports of suicidality in clinical trials of montelukast.

Philip G, Hustad C, Noonan G, Malice MP, Ezekowitz A, Reiss TF, Knorr B. Philip G, et al. Among authors: knorr b. J Allergy Clin Immunol. 2009 Oct;124(4):691-6.e6. doi: 10.1016/j.jaci.2009.08.010. J Allergy Clin Immunol. 2009. PMID: 19815114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters